维普中文期刊产品整合服务
19篇 您的检索式:作者名="Goeser"
    题名 作者 年代 出处 被引量
1Characterization of antigenic determinants in the core antigen of the hepatitis C virus 显示文摘Goeser T Muller HM Ye J 1994Virology1994,205,2:1
2Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication显示文摘Muller HM Pfaff E Goeser T Kallinowski B Solbach C Theilmann L 0,,:1
3Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication显示文摘Muller HM Pfaff E Goeser T 0,,:1
4Diagnostic imaging of ventriculoperitoneal shunt malfunctions and complications 显示文摘Goeser CD McLeary MS Young LW 1998Radiographics1998,18,3:1
5Virological analysis of patients receiving telaprevir administered q8h or ql2h with peginterferon-alfa-2a or -alfa-2b and ribavirin inn treatment-naive patients with genotype-1 hepatitis C:study C208显示文摘Marcellin P Foms X Goeser Hepatology0,,:1
6Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-na?ve patients infected with HCV genotype 1显示文摘Lawrence Serfaty Xavier Forns Tobias Goeser Peter Ferenci Frederik Nevens Giampiero Carosi Joost P Drenth Isabelle Lonjon-Domanec Ralph DeMasi Gaston Picchio Maria Beumont Patrick Marcellin 2012Gut2012,,10:1
7Peripheral blood leukocytes ser ve as a possible extrahepatic site for hepatitis C virus replication显示文摘 Praff E Goeser T 1993J Gen Vir1993,74,:1
8Characterazation of antigenic determinants in the core antigen of the hepatitis C virus 显示文摘Goeser T Muller H M Ye J 1994Virology1994,205,2:1
9Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-na?ve patients infected with HCV genotype 1显示文摘Lawrence Serfaty Xavier Forns Tobias Goeser Peter Ferenci Frederik Nevens Giampiero Carosi Joost P Drenth Isabelle Lonjon-Domanec Ralph DeMasi Gaston Picchio Maria Beumont Patrick Marcellin 2012Gut2012,,10:1
10Virological analysis of patients receiving telaprevir administered QSH or Q12H with peginterferon-alfa-aa or -alfa- 2b and ribavirin in treatmenVnaive patients with genotype 1 hepatitis C: study C208显示文摘Marcellin P Forns X Goeser T 2009Hepatology2009,50,4:1
11Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-na?ve patients infected with HCV genotype 1显示文摘Lawrence Serfaty Xavier Forns Tobias Goeser Peter Ferenci Frederik Nevens Giampiero Carosi Joost P Drenth Isabelle Lonjon-Domanec Ralph DeMasi Gaston Picchio Maria Beumont Patrick Marcellin 2012Gut2012,,10:1
12Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C显示文摘Patrick Marcellin Xavier Forns Tobias Goeser Peter Ferenci Frederik Nevens Giampiero Carosi Joost P. Drenth Lawrence Serfaty Koen De Backer Rolf Van Heeswijk Donghan Luo Gaston Picchio Maria Beumont 2011Gastroenterology2011,,2:1
13Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin显示文摘Thomas Berg Michael von Wagner Samer Nasser Christoph Sarrazin Tobias Heintges Tilman Gerlach Peter Buggisch Tobias Goeser Jens Rasenack Gerd R. Pape Wolfgang E. Schmidt Birgit Kallinowski Hartwig Klinker Ulrich Spengler Peter Martus Ulrich Alshuth Stefan 2006Gastroenterology2006,,4:1
14The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites显示文摘Philipp Lutz Kenneth Pfarr Hans Dieter Nischalke Benjamin Kr?mer Felix Goeser Andreas Gl?ssner Franziska Wolter Pavlos Kokordelis Jacob Nattermann Tilman Sauerbruch Achim Hoerauf Christian P. Strassburg Ulrich Spengler 2015Clinical Chemistry and Laboratory Medicine (CCLM)2015,,12:1
15Telaprevir is effective given every 8 or 12 hours with ribavirin and peginterferon alfa-2a or-2b to patients with chronic hepatitis C显示文摘Marcellin P Foms X Goeser T 0,,2:1
16An alternative method to assess 24-h ruminal in vitro neutral detergent fiber digestibility 显示文摘GOESER J P COMBS D K 2008J Dairy Sei2008,92,8:1
17Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-na?ve patients infected with HCV genotype 1显示文摘Lawrence Serfaty Xavier Forns Tobias Goeser Peter Ferenci Frederik Nevens Giampiero Carosi Joost P Drenth Isabelle Lonjon-Domanec Ralph DeMasi Gaston Picchio Maria Beumont Patrick Marcellin 2012Gut2012,,10:1
18肌钙蛋白I在心肌中介导严重的自体免疫炎症反应显示文摘Goeser S Andrassy M Buss SJ 邓晓奇(摘译) 余秀琼(校) 2007心血管病学进展2007,28,1:0
19Management of decompensated liver cirrhosis in the surgical intensive care unit显示文摘Liver cirrhosis is the end-stage of chronic progressive liver diseases(1).The most common causes of cirrhosis worldwide include alcohol-related liver disease,non-alcoholic fatty liver disease,hepatitis B,hepatitis C,autoimmune liver diseases(e.g.,autoimmune hepatitis),cholestatic liver diseases(e.g.,primary biliary cholangitis,primary sclerosing cholangitis),hemochromatosis or Wilsons’disease(1).Philipp Kasper Tobias Goeser 2023Hepatobiliary Surgery and Nutrition2023,12,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费